» Articles » PMID: 7258098

Electrophysiologic Studies of Supraventricular Tachycardia in Children. I. Clinical-electrophysiologic Correlations

Overview
Journal Am Heart J
Date 1981 Aug 1
PMID 7258098
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the clinical features, surface ECG findings, associated with congenital heart disease (CHD), and status at follow-up in 103 children who underwent intracardiac electrophysiologic evaluation of supraventricular tachycardia (SVT). Age at catheterization ranged from 2 days to 17 years (mean 4.2 years). Diagnosis of the mechanism was based upon standard electrophysiologic techniques. Of the 103 patients, 37 had reentry without a bypass tract (10 sinoatrial node, two atrial muscle, and 25 atrioventricular node); 51 had reentry with a bypass tract (28 manifest Wolff-Parkinson-White [WPW], 18 unidirectional retrograde accessory pathway [URAP], an five Lown-Ganong-Levine); and 15 had an ectopic focus (11 atrial, four junctional). Distinguishing features among the common types are depicted in Table III. We conclude that in children the various mechanisms of SVT (1) are likely to be found in different clinical situations, (2) have a different potential for surgical cure, and (3) have a different prognosis for long-term treatment. Since curative surgery was theoretically possible in 57% of our patients (WPW, concealed WPW, atrial, and junctional ectopic), we recommend electrophysiologic study in any patient who has had frequent recurrences of SVT for longer than 1 year and who requires drugs in addition to digoxin for treatment.

Citing Articles

Transcatheter ablation of atrioventricular nodal reentry tachycardia in children and congenital heart disease in the era of 3D mapping.

Drago F, Flore F, Raimondo C, Pandozi C Front Cardiovasc Med. 2024; 11:1506858.

PMID: 39669410 PMC: 11634858. DOI: 10.3389/fcvm.2024.1506858.


Inhaled Short-Acting Beta Agonist Treatment-Associated Supraventricular Tachycardia in Children: Still a Matter of Concern in Pediatric Emergency Departments?.

Tchana B, Caffarelli C Children (Basel). 2023; 10(4).

PMID: 37189948 PMC: 10137101. DOI: 10.3390/children10040699.


Management of Supraventricular Tachycardia in Infants.

Richardson C, Silver E Paediatr Drugs. 2017; 19(6):539-551.

PMID: 28861756 DOI: 10.1007/s40272-017-0254-0.


Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database.

Chu P, Hill K, Clark R, Smith P, Hornik C Early Hum Dev. 2015; 91(6):345-50.

PMID: 25933212 PMC: 4433846. DOI: 10.1016/j.earlhumdev.2015.04.001.


Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants.

Hornik C, Chu P, Li J, Clark R, Smith P, Hill K Pediatr Crit Care Med. 2014; 15(9):839-45.

PMID: 25072477 PMC: 4221410. DOI: 10.1097/PCC.0000000000000229.